Online survey for patients affected by non-tuberculous mycobacteria lung disease

(NTM-LD) in Europe

E N P A D E

European NTM lung disease Patient Disease Experience survey

Thanks

Dear visitor,

Thank you for your interest in the ENPADE survey. The ENPADE survey was successfully completed at the end of February 2022 and is currently being evaluated. After the evaluation the results will be made public.

We would like to express our sincere thanks to all participants.

The ENPADE Team

 

Supported by

If you have any further questions, please do not hesitate to send us an e-mail on info@admedicum.com

en_GB